Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.
about
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseDevelopment of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy.Nanoformulations for combination or cascade anticancer therapy.Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy.iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells.
P2860
Q28073219-D333E5CD-CE93-4089-B0EC-FCFB74DF4FC2Q33739032-C7CE598E-85A5-47D7-B983-D55150C5DA73Q37469872-D2F424DF-1CB0-4517-BF9D-9F3C30597A24Q38762779-2954794D-37DD-458F-BC30-DAC5841CCF90Q38874499-20068010-A186-4BA3-96B4-4211E471BAABQ39380111-768EAA65-4D3D-4638-A1AD-30356F3E3F36Q41095468-B16869FF-323D-4CAB-9D19-91CD95690375Q46272530-17414262-3D2D-4474-9447-7D279B402CB6Q47815925-FE39FD0F-3F95-4542-93C3-E58B11F5E9D8Q47980720-4B90DCB7-E502-4525-A109-4D2E9A8B4585Q49714833-237FCEA7-E988-407D-89A2-827CB5299E41Q50224155-3F96FCF9-53A2-40C2-B866-D0397A9F6A83
P2860
Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Co-delivery of camptothecin an ...... ncer combination chemotherapy.
@ast
Co-delivery of camptothecin an ...... ncer combination chemotherapy.
@en
type
label
Co-delivery of camptothecin an ...... ncer combination chemotherapy.
@ast
Co-delivery of camptothecin an ...... ncer combination chemotherapy.
@en
prefLabel
Co-delivery of camptothecin an ...... ncer combination chemotherapy.
@ast
Co-delivery of camptothecin an ...... ncer combination chemotherapy.
@en
P2093
P2860
P921
P356
P1476
Co-delivery of camptothecin an ...... ancer combination chemotherapy
@en
P2093
Didier Merlin
Mingzhen Zhang
Moon Kwon Han
Xiaoying Si
P2860
P304
P356
10.1039/C5TB01245G
P407
P577
2015-09-01T00:00:00Z